StockData

Bambusa Therapeutics, Inc. (BBTX) income statement

BBTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$16.00+0.45 (+2.89%)

Close on Nov 20, 2026Market cap –P/E –Yield –

Bambusa Therapeutics, Inc. financial ratios

Not enough reported data yet to compute ratios by period.

See a number that looks wrong?